Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

XiVE S plus Impl D3.8/L11: medical device reports filed with FDA

5,171 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

5,171
device reports naming the brand
0% of all MAUDE reports · about 730 a year
506
reports, 12 months to August 2026
735 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 5,171 reports that name the brand "XiVE S plus Impl D3.8/L11" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

506 reports arrived in the 12 months to August 2026, down 31% from 735 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (35.2%), osseointegration problem (32.2%) and loss of osseointegration (25.7%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

058115Sep 2021: 30Oct 2021: 53Nov 2021: 86Dec 2021: 572022Jan 2022: 106Feb 2022: 89Mar 2022: 53Apr 2022: 84May 2022: 108Jun 2022: 85Jul 2022: 72Aug 2022: 92Sep 2022: 59Oct 2022: 53Nov 2022: 79Dec 2022: 942023Jan 2023: 78Feb 2023: 80Mar 2023: 58Apr 2023: 89May 2023: 91Jun 2023: 81Jul 2023: 81Aug 2023: 41Sep 2023: 74Oct 2023: 63Nov 2023: 81Dec 2023: 862024Jan 2024: 63Feb 2024: 91Mar 2024: 79Apr 2024: 74May 2024: 74Jun 2024: 82Jul 2024: 58Aug 2024: 74Sep 2024: 61Oct 2024: 83Nov 2024: 47Dec 2024: 372025Jan 2025: 57Feb 2025: 53Mar 2025: 115Apr 2025: 19May 2025: 53Jun 2025: 51Jul 2025: 95Aug 2025: 64Sep 2025: 53Oct 2025: 49Nov 2025: 41Dec 2025: 322026Jan 2026: 59Feb 2026: 35Mar 2026: 30Apr 2026: 40May 2026: 45Jun 2026: 48Jul 2026: 32Aug 2026: 42

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

06721,3432019: 11520192021: 1,34320212022: 97420222023: 90320232024: 82320242025: 68220252026: 3312026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%5,169
Malfunction0%2
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%5,171
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,81935.2%62.8%
Osseointegration problem1,66732.2%7.7%
Loss of osseointegration1,32925.7%22.4%
Fracturea broken bone3496.7%1.6%
Damaged thread60.1%0%
Loosening of implant not related to bone-ingrowth60.1%0.1%
Malposition of device30.1%0.1%
Off-label use30.1%0%
Separation failure20%0.1%
Crackthe device cracked10%0%
Insufficient device problem information10%0.2%
Material deformation10%0.1%
Mechanical problema mechanical problem10%0.1%
Migration or expulsion of device10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant5,16299.8%
Inflammationinflammation69013.3%
Osteolysis3396.6%
Pocket erosion2013.9%
Implant pain130.3%
Inadequate osseointegration110.2%
Painpain, site not specified70.1%
Fistula20%
Deformity/ disfigurement10%
Discomfortdiscomfort10%
Impaired healingslow healing10%
Necrosisdeath of tissue10%
Osteopenia/ osteoporosis10%
Sinus perforation10%
Wound dehiscencea wound reopened10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureXiVE S plus Impl D3.8/L11Product code DZEAll MAUDE reports
Reports5,1713,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about XiVE S plus Impl D3.8/L11 reports

How many FDA reports name XiVE S plus Impl D3.8/L11?

5,171 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 506 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (35.2%), osseointegration problem (32.2%), loss of osseointegration (25.7%), fracture (6.7%) and damaged thread (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that XiVE S plus Impl D3.8/L11 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.